KFDA label changes for 16 active ingredients including Reductil

Published: 2006-05-17 07:00:00

Updated: 2006-05-17 07:00:00

The KFDA announced on May 12 that the labels of drugs containing 16 active ingredients including sibutramine (Reductil) had been changed. The label changes included warning descriptions for Reductil that may happen to cause hypertension, headache and dizziness. Reductil (Abbott) was contra-indica...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK